Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis. Επικοινωνία Submitted by Απόστολος Τσάπας on Τετ, 10/12/2022 - 09:18
